Radiotherapy and Pancreatic Adenocarcinoma

Posted On 2018-09-04 15:03:02

Simultaneous improvements in genomic assays, novel targeted small molecule and antibody-based therapies, as well as technologies used to deliver and assess response to radiotherapy have led to renewed investigation of radiotherapy for pancreatic cancer and are presented in this special series of Annals of Pancreatic Cancer (APC).

The series “Radiotherapy and Pancreatic Adenocarcinoma” was commissioned by the editorial office, Annals of Pancreatic Cancer without any sponsorship or funding. Richard Tuli served as the unpaid Guest Editor for the series.